Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Iris Schrader"'
Autor:
Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-11 (2020)
Abstract Background When chemotherapy is indicated in patients with early breast cancer, regimens that contain anthracyclines and taxanes are established standard treatments. Gemcitabine has shown promising effects on the response and prognosis in pa
Externí odkaz:
https://doaj.org/article/41e6c37d4d19434583b0e8de81ad13a2
Autor:
Klaus Pantel, Michael Untch, Gunter von Minckwitz, Christian Schem, Hans Tesch, Frank Holms, Jörn Hilfrich, Iris Schrader, Tanja Fehm, Jens Huober, Karsten Weber, Valentina Nekljudova, Sibylle Loibl, Volkmar Müller, Sabine Riethdorf
Changes of CTC numbers in the total study cohort or in any of the different subgroups were not related to DFS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3382c7c74b6d8f7cd11cbc8ea2afaaae
https://doi.org/10.1158/1078-0432.22468463
https://doi.org/10.1158/1078-0432.22468463
Autor:
Klaus Pantel, Gunter von Minckwitz, Michael Untch, Holger Eidtmann, Hans Tesch, Frank Holms, Jörn Hilfrich, Iris Schrader, Tanja Fehm, Jens Huober, Marc Roller, Martina Komor, Sibylle Loibl, Thomas Rau, Liling Zhang, Volkmar Müller, Sabine Riethdorf
Supplementary Data from Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7717b1e7e3dfcd04d4669cb6dca8f03b
https://doi.org/10.1158/1078-0432.22440604.v1
https://doi.org/10.1158/1078-0432.22440604.v1
Autor:
Sibylle Loibl, Michael Untch, Valentina Nekljudova, Tanja Fehm, Brian Leyland-Jones, Marion van Mackelenbergh, Jens Huober, Elmar Stickeler, Claus Hanusch, Brandon M. Young, Christian Schem, Bernd Gerber, Uwe Holtrich, Volkmar Müller, Frederik Marmé, Jan Budczies, Iris Schrader, Bruno V. Sinn, Peter A. Fasching, Knut Engels, Carsten Denkert, Christine Solbach, Karsten E. Weber, Tobias Meissner, Thomas Karn
Correlation of Affymetrix microarray expression data and IHC scoring of three genes in independent TNBC dataset
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b486e86cf44e844dd49b0cf8194558
https://doi.org/10.1158/1078-0432.22479458.v1
https://doi.org/10.1158/1078-0432.22479458.v1
Autor:
Klaus Pantel, Michael Untch, Gunter von Minckwitz, Christian Schem, Hans Tesch, Frank Holms, Jörn Hilfrich, Iris Schrader, Tanja Fehm, Jens Huober, Karsten Weber, Valentina Nekljudova, Sibylle Loibl, Volkmar Müller, Sabine Riethdorf
Purpose: This study aimed to evaluate the prognostic impact of circulating tumor cells (CTC) detected in patients with operable or locally advanced breast cancer before and after neoadjuvant therapy (NT) within the clinical trial GeparQuattro.Experim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b0662051f74418b99afb6fef89916ac
https://doi.org/10.1158/1078-0432.c.6526955.v1
https://doi.org/10.1158/1078-0432.c.6526955.v1
Autor:
Klaus Pantel, Michael Untch, Gunter von Minckwitz, Christian Schem, Hans Tesch, Frank Holms, Jörn Hilfrich, Iris Schrader, Tanja Fehm, Jens Huober, Karsten Weber, Valentina Nekljudova, Sibylle Loibl, Volkmar Müller, Sabine Riethdorf
Changes of CTC numbers in the total study cohort or in any of the different subgroups were not related to OS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::512f5f95362fbc83d560f3d0d07abefd
https://doi.org/10.1158/1078-0432.22468460
https://doi.org/10.1158/1078-0432.22468460
Autor:
Klaus Pantel, Michael Untch, Gunter von Minckwitz, Christian Schem, Hans Tesch, Frank Holms, Jörn Hilfrich, Iris Schrader, Tanja Fehm, Jens Huober, Karsten Weber, Valentina Nekljudova, Sibylle Loibl, Volkmar Müller, Sabine Riethdorf
Supplementary Figure S1: Kaplan Meier plots for disease-free (DFS) and overall survival (OS) according CTC detection after NT. (A, B) DFS, analysis of the whole patient cohort at CTC cut-offs {greater than or equal to}1 (A) and {greater than or equal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14f4e293e85443455996175c2d65a4cb
https://doi.org/10.1158/1078-0432.22468481
https://doi.org/10.1158/1078-0432.22468481
Autor:
Klaus Pantel, Michael Untch, Gunter von Minckwitz, Christian Schem, Hans Tesch, Frank Holms, Jörn Hilfrich, Iris Schrader, Tanja Fehm, Jens Huober, Karsten Weber, Valentina Nekljudova, Sibylle Loibl, Volkmar Müller, Sabine Riethdorf
Detection of CTCs associated with patient and tumor characteristics for both time points in patients with measurements at both time points is listed. There was no significant correlation of {greater than or equal to}1CTC or {greater than or equal to}
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64c72830b620d8c5608887c40025c8f5
https://doi.org/10.1158/1078-0432.22468466.v1
https://doi.org/10.1158/1078-0432.22468466.v1
MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients
Autor:
Hanna Huebner, Lothar Häberle, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Visnja Fink, Fabienne Schochter, Inga Bekes, Sven Mahner, Julia Jückstock, Naiba Nabieva, Andreas Schneeweiss, Hans Tesch, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Mahdi Rezai, Matthias W. Beckmann, Peter A. Fasching, Wolfgang Janni, Brigitte Rack
Publikováno v:
Cancers; Volume 14; Issue 7; Pages: 1721
Simple Summary CA27.29 (MUC1) is a well described biomarker for prediction of prognosis and treatment efficacy. CA27.29 is mainly evaluated in the preoperative setting. However, testing of postoperative levels and additional assessment after chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8316ff3231a8d1ab6016a6034777f834
Autor:
Oliver J. Stoetzer, Doris Augustin, Kerstin Lüdtke-Heckenkamp, Nadia Harbeck, J. Tio, Ulrike Nitz, Petra Krabisch, Andrea Grafe, Andrea Stefek, Monika Graeser, Ronald E. Kates, Rachel Wuerstlein, Oleg Gluz, D Forstmeyer, Iris Schrader, Helmut Forstbauer, Eva-Maria Grischke, Gabriele Kaltenecker, Raquel von Schumann
Publikováno v:
Breast Care (Basel)
Background: Protroca evaluated the efficacy and safety of primary and secondary prophylaxis of neutropenia with lipegfilgrastim (Lonquex®) in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy (CT). Patients and Methods: Of the 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d45acfaf39bd5fd5f7d2180e5b4bec2a
https://doi.org/10.1159/000506622
https://doi.org/10.1159/000506622